What is the fair value of Pd-Rx Pharmaceutical (OTC-PDRX) stock?

The current fair value estimate for Pd-Rx Pharmaceutical (OTC-PDRX) is $3.66. This implies an estimated upside of 18.0% versus the current market price.

Is Pd-Rx Pharmaceutical (OTC-PDRX) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 18.0% versus the current market price.

How is the financial health of Pd-Rx Pharmaceutical?

The current financial health read for Pd-Rx Pharmaceutical (OTC-PDRX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Pd-Rx Pharmaceutical's next earnings date?

The next earnings date currently listed for Pd-Rx Pharmaceutical (OTC-PDRX) is October 15, 2026.

Does Pd-Rx Pharmaceutical (OTC-PDRX) pay dividends?

The latest available data indicates no current dividend yield for Pd-Rx Pharmaceutical (OTC-PDRX).

What is the market capitalization of Pd-Rx Pharmaceutical?

The current market capitalization listed for Pd-Rx Pharmaceutical is 5.099 M.

What is the enterprise value of Pd-Rx Pharmaceutical?

The current enterprise value listed for Pd-Rx Pharmaceutical is -1.067 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Pd-Rx Pharmaceutical?

The ticker symbol for Pd-Rx Pharmaceutical is OTC-PDRX, and the stock is listed on OTC Markets.

Where is Pd-Rx Pharmaceutical (OTC-PDRX) listed?

Pd-Rx Pharmaceutical (OTC-PDRX) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Pd-Rx Pharmaceutical?

The current debt-to-total-capital ratio listed for Pd-Rx Pharmaceutical is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

Pd-Rx Pharmaceutical (PDRX) Fair Value & Stock Analysis

Pd-Rx Pharmaceutical (PDRX)

Pd-Rx Pharmaceutical, Inc. is a common stock listing on OTC Markets tied to a healthcare company focused on pharmaceutical repackaging and distribution in the United States. The company works with prepackaged drug products, including topical preparations, ophthalmic and otic items, liquids, and suspensions, and also provides related packaging services. Its product and service set includes a manual dispensing platform, the PD-Rx Net web application for prescription tracking and label printing at the point of care, and physician dispensing support for settings such as primary care, urgent care, pain management, occupational and orthopedic medicine, bariatric care, and dental practices. Incorporated in 1986, the company is based in Oklahoma City, Oklahoma.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Cash Flow / Net Income
OTC-PDRX	$3.66	18.0% Upside	Fair	Not available	Not available	Fair	0.0%	October 15, 2026	0.3x	5.099 M	-1.067 M	0.0%	-296.1%